Page last updated: 2024-11-08

anacardic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

anacardic acid: isolated from Anacardium occidentale; monophenol monooxygenase inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

anacardic acid : A hydroxybenzoic acid that is salicylic acid substituted by a pentadecyl group at position 6. It is a major component of cashew nut shell liquid and exhibits an extensive range of bioactivities. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
AnacardiumgenusA plant genus of the family ANACARDIACEAE. This is the source of the familiar cashew nuts, which are heat treated to remove the irritant toxin. Cashew nut shell liquid (frequently abbreviated as CNSL) is a major source of alkenyl phenolic compounds, especially ANACARDIC ACIDS, cardol, and cardanol.[MeSH]AnacardiaceaeThe sumac plant family in the order Sapindales, subclass Rosidae, class Magnoliopsida. They are tropical and subtropical trees, shrubs, and woody vines that have resin ducts in the bark. The sap of many of the species is irritating to the skin.[MeSH]

Cross-References

ID SourceID
PubMed CID167551
CHEMBL ID33778
CHEBI ID2696
SCHEMBL ID627981
MeSH IDM0233241

Synonyms (59)

Synonym
nsc-623096
nsc623096
nsc-229596
nsc229596
2-hydroxy-6-pentadecylbenzoic acid
2-hydroxy-6-pentadecyl-benzoic acid
nsc333857
nsc-333857
benzoic acid,
pa-9a
anacardic acid
6-pentadecylsalicylic acid
16611-84-0
bdbm50240436
cyclogallipharic acid
benzoic acid, 2-hydroxy-6-pentadecyl-
nsc 333857
CHEMBL33778
chebi:2696 ,
anarcadic acid
6-(pentadecyl)salicylic acid
22:0-anacardic acid
S7582
BRD-K66989831-001-01-3
CCG-208707
SCHEMBL627981
anacardsaure
pentadecylsalicylic acid, 6-
anacardic acid a
ADFWQBGTDJIESE-UHFFFAOYSA-N
HB1380
AKOS024457416
c22h36o3
ginkgolic acid c15:0
DTXSID00168078
mfcd07368254
LMPK15040002
6-pdsa
(15:0)-anacardic acid, analytical standard
hydroginkgolic acid
AS-63256
J-010259
(15:0)-anacardic acid
anacardic acid - cas 16611-84-0
HY-N2020
CS-0018377
BCP27645
A14226
HMS3426M05
EX-A3352
FT-0777685
NCGC00263625-09
A925109
2-hydroxy-6-pentadecylbenzoicacid
ns- 623096
6-pentadecyl-2-hydroxybenzoic acid
salicylic acid, 6-pentadecyl-
8H693KBS2W
2-oxidanyl-6-pentadecyl-benzoic acid

Research Excerpts

Overview

Anacardic acid (AA) is a natural component extracted from cashew nut shells, which has been reported to have neuroprotective effects in traumatic brain injury. It is a potent epigenetic agent with anticancer activity.

ExcerptReferenceRelevance
"Anacardic acid (AA) is a phenolic acid extract found in a number of plants, crops, and fruits. "( Treatment with anacardic acid modulates dendritic cell activation and alleviates the disease development of autoimmune neuroinflammation in mice.
Gao, MY; Gao, R; Gao, YH; Guo, YX; Li, X; Sun, YN; Wang, JQ; Wang, LB; Zhang, Y; Zhao, ZH, 2022
)
2.52
"Anacardic acid (AA) is a natural component extracted from cashew nut shells, which has been reported to have neuroprotective effects in traumatic brain injury."( Anacardic acid improves neurological deficits in traumatic brain injury by anti-ferroptosis and anti-inflammation.
Chen, Z; Guo, J; Ji, H; Li, J; Liu, Y; Ma, Y; Zhao, Z; Zheng, J, 2023
)
3.07
"Anacardic acid (AnAc) is a dietary phenolic lipid that inhibits both MCF-7 estrogen receptor α (ERα) positive and MDA-MB-231 triple negative breast cancer (TNBC) cell proliferation with IC50s of 13.5 and 35 μM, respectively."( Genome-wide miRNA response to anacardic acid in breast cancer cells.
Alizadeh-Rad, N; Green, MA; Klinge, CM; Muluhngwi, P; Rouchka, EC; Schultz, DJ; Waigel, SJ, 2017
)
1.47
"Anacardic acid is a potent epigenetic agent with anticancer activity."( Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines - in vitro studies.
Filipczak, N; Gubernator, J; Kozubek, A; Legut, M; Lipka, D; Piwoni, A, 2014
)
2.57
"Anacardic acid (AA) is a mixture of 2-hydroxy-6-alkylbenzoic acid homologs. "( Anacardic acid enhances the proliferation of human ovarian cancer cells.
Chen, S; Gou, WF; Takano, Y; Xiu, YL; Zhao, Y; Zheng, HC, 2014
)
3.29
"Anacardic acid (AnA) is a phytochemical compound that can inhibit the activity of various cellular enzymes including histone acetyltransferases (HATs)."( The inhibitory effects of anacardic acid on hepatitis C virus life cycle.
Hundt, J; Li, Z; Liu, Q, 2015
)
1.44
"Anacardic acid is a major constituent of nutshell of cashew. "( Anti-metastatic action of anacardic acid targets VEGF-induced signalling pathways in epithelial to mesenchymal transition.
Kaveri, K; Salimath, BP; Shilpa, P, 2015
)
2.16
"Anacardic acid is a dietary and medicinal phytochemical that inhibits breast cancer cell proliferation and uncouples oxidative phosphorylation (OXPHOS) in isolated rat liver mitochondria. "( Anacardic Acid, Salicylic Acid, and Oleic Acid Differentially Alter Cellular Bioenergetic Function in Breast Cancer Cells.
Alizadeh-Rad, N; Klinge, CM; Price, SM; Radde, BN; Schultz, DJ, 2016
)
3.32
"Anacardic acid is a medicinal phytochemical that inhibits proliferation of fungal as well as several types of cancer cells. "( Apoptosis-inducing factor (Aif1) mediates anacardic acid-induced apoptosis in Saccharomyces cerevisiae.
Chattoo, BB; Muzaffar, S, 2017
)
2.16
"Anacardic acid (AA) is a bioactive phytochemical found in nutshell of Anacardium occidentale. "( Emerging roles of anacardic acid and its derivatives: a pharmacological overview.
Girish, KS; Hemshekhar, M; Kemparaju, K; Sebastin Santhosh, M, 2012
)
2.16
"Anacardic acid (AA) is a constituent of the cashew nut shell and is known as an inhibitor of nuclear factor-κB (NF-κB). "( Anacardic acid induces mitochondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells.
Kim, GD; Seong, YA; Shin, PG, 2013
)
3.28
"Anacardic acid is an alkylsalicylic acid obtained from cashew-nut-shell liquid, and is a potent inhibitor of p300 histone acetyl-transferase (HAT) activity. "( The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin.
Balasubramanyam, K; Carroll, C; Davidson, SM; Ganesan, A; Kundu, TK; Latchman, DS; Packham, G; Stephanou, A; Townsend, PA; Yurek-George, A, 2005
)
1.77

Effects

ExcerptReferenceRelevance
"Anacardic acid (AA) has several pharmacological actions, such as antioxidants, anticholinesterase, and anti-inflammatory, which are related to the protection against aging disorders."( Anacardic Acid Complexes as Possible Agents Against Alzheimer's Disease Through Their Antioxidant, In vitro, and In silico Anticholinesterase and Ansiolic Actions.
Alves, DR; da Silva, WMB; de Menezes, JESA; de Morais, SM; Magalhães, FEA; Marinho, ES; Marinho, MM; Pinheiro, SO; Silva, FCO, 2021
)
2.79

Treatment

Anacardic acid treatment suppressed paw swelling, joint destruction, and arthritis scores in CIA mice. Treatment leads to decrease in reactive oxygen species (ROS) accumulation normally observed during apoptosis.

ExcerptReferenceRelevance
"Anacardic acid treatment markedly suppressed paw swelling, joint destruction, and arthritis scores in CIA mice."( Anacardic acid suppresses fibroblast-like synoviocyte proliferation and invasion and ameliorates collagen-induced arthritis in a mouse model.
Meng, Y; Wang, N; Wang, YS; Yang, GH; Zhang, C, 2018
)
2.64
"Anacardic acid treatment leads to decrease in reactive oxygen species rather than increase in reactive oxygen species (ROS) accumulation normally observed during apoptosis, confirming the antioxidant properties of anacardic acid as suggested by earlier reports."( Anacardic acid induces apoptosis-like cell death in the rice blast fungus Magnaporthe oryzae.
Banerji, A; Bose, C; Chattoo, BB; Muzaffar, S; Nair, BG, 2016
)
2.6

Compound-Compound Interactions

ExcerptReferenceRelevance
"The inhibitory and bactericidal activities of anacardic acid and totarol, alone and in combination with methicillin, were investigated against methicillin-resistant Staphylococcus aureus (MRSA)."( Antibacterial activity of anacardic acid and totarol, alone and in combination with methicillin, against methicillin-resistant Staphylococcus aureus.
Kubo, I; Muroi, H, 1996
)
0.85

Dosage Studied

ExcerptRelevanceReference
" Analysis of dose-response curves indicated a significant effect on weight gain and mortality."( Bioactivity of anacardic acid against colorado potato beetle (Leptinotarsa decemlineata) larvae.
Cobbs, GA; Olsen, C; Parrott, MM; Schultz, DJ; Stolowich, NJ, 2006
)
0.69
" Intermittent steroid dosing has been proposed in Duchenne Muscular Dystrophy patients to mitigate the side effects seen with daily steroid intake."( Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming.
Barish, GD; Bass, J; Demonbreun, AR; Haldar, SM; Jiang, Z; Kuntz, NL; McNally, EM; Peek, CB; Quattrocelli, M; Zelikovich, AS, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (8)

RoleDescription
EC 2.3.1.48 (histone acetyltransferase) inhibitorAn EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor that interferes with the function of histone acetyltransferase (EC 2.3.1.48).
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
neuroprotective agentAny compound that can be used for the treatment of neurodegenerative disorders.
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitorAn EC 3.4.22.* (cysteine endopeptidase) inhibitor that interferes with the action of SARS coronavirus main proteinase (EC 3.4.22.69).
anticoronaviral agentAny antiviral agent which inhibits the activity of coronaviruses.
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
hydroxybenzoic acidAny benzoic acid carrying one or more phenolic hydroxy groups on the benzene ring.
hydroxy monocarboxylic acidAny monocarboxylic acid which also contains a separate (alcoholic or phenolic) hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (12)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Seed linoleate 13S-lipoxygenase-1Glycine max (soybean)IC50 (µMol)51.90000.07002.12673.5000AID713977
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)8.92000.00022.45859.9600AID1803986; AID1891410
Histone acetyltransferase p300Homo sapiens (human)IC50 (µMol)7.41250.26004.00008.5000AID1282361; AID1282369; AID1422597; AID1528818
Histone acetyltransferase KAT2BHomo sapiens (human)IC50 (µMol)19.45005.00006.01678.5000AID1203126; AID1282370; AID1282371; AID1422598
Histone acetyltransferase KAT5Homo sapiens (human)IC50 (µMol)64.00002.00003.75009.0000AID1422599
SUMO-activating enzyme subunit 1Homo sapiens (human)IC50 (µMol)2.20002.20004.46678.2000AID727132
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2EC50 (µMol)3.98000.00304.11059.8200AID1803987
Peroxisome proliferator-activated receptor gammaHomo sapiens (human)EC50 (µMol)17.00000.00000.992210.0000AID1901641
Peroxisome proliferator-activated receptor alphaHomo sapiens (human)EC50 (µMol)3.50000.00061.607410.0000AID1901640
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Histone acetyltransferase p300Homo sapiens (human)INH8.50008.50008.50008.5000AID1377703
Histone acetyltransferase KAT8Homo sapiens (human)Km1.76671.00001.76672.4000AID1262170; AID1262171; AID1262172
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (257)

Processvia Protein(s)Taxonomy
Factor XII activationPlasma kallikreinHomo sapiens (human)
proteolysisPlasma kallikreinHomo sapiens (human)
blood coagulationPlasma kallikreinHomo sapiens (human)
zymogen activationPlasma kallikreinHomo sapiens (human)
plasminogen activationPlasma kallikreinHomo sapiens (human)
fibrinolysisPlasma kallikreinHomo sapiens (human)
positive regulation of fibrinolysisPlasma kallikreinHomo sapiens (human)
negative regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of cholesterol effluxPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
long-chain fatty acid transportPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of osteoblast differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of smooth muscle cell proliferationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of receptor signaling pathway via STATPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of low-density lipoprotein receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of signaling receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of BMP signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of MAP kinase activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of adiponectin secretionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of cardiac muscle hypertrophy in response to stressPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of connective tissue replacement involved in inflammatory response wound healingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
placenta developmentPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
lipid metabolic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
signal transductionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
G protein-coupled receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
response to nutrientPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of blood pressurePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of lipid storagePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of sequestering of triglyceridePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of angiogenesisPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
monocyte differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
BMP signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
epithelial cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cellular response to insulin stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
response to lipidPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
peroxisome proliferator activated receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
glucose homeostasisPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of circadian rhythmPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
mRNA transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
lipoprotein transportPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of blood vessel endothelial cell migrationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
innate immune responsePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cell fate commitmentPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of fat cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
retinoic acid receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cell maturationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
rhythmic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
white fat cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
lipid homeostasisPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of SMAD protein signal transductionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of cholesterol transporter activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cellular response to low-density lipoprotein particle stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cellular response to hypoxiaPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of mitochondrial fissionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of cellular response to insulin stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of extracellular matrix assemblyPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of miRNA transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of cellular response to transforming growth factor beta stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of adipose tissue developmentPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of vascular associated smooth muscle cell proliferationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell apoptotic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of vascular endothelial cell proliferationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
glucose metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
generation of precursor metabolites and energyPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
lipid metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid beta-oxidationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
apoptotic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
embryo implantationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cholesterol metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cell population proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
axon ensheathmentPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid catabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of gene expressionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
regulation of skeletal muscle satellite cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid transportPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
intracellular receptor signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cell-substrate adhesionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cellular response to nutrient levelsPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
wound healingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
steroid hormone mediated signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of skeletal muscle tissue regenerationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
keratinocyte proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of fat cell differentiationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of myoblast differentiationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
decidualizationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of epithelial cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
keratinocyte migrationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
adipose tissue developmentPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fat cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of fat cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cellular response to hypoxiaPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
energy homeostasisPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
apoptotic signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
glucose transmembrane transportPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of myoblast proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor deltaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of cytokine production involved in inflammatory responsePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of reactive oxygen species biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of hepatocyte apoptotic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of signaling receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of ATP biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of transformation of host cell by virusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to hypoxiaPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
gluconeogenesisPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
heart developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to nutrientPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
epidermis developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cellular response to starvationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of cellular ketone metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of sequestering of triglyceridePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
intracellular receptor signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid beta-oxidationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of appetitePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to insulinPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
circadian regulation of gene expressionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
behavioral response to nicotinePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
wound healingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
lipoprotein metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of circadian rhythmPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
steroid hormone mediated signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to ethanolPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of gluconeogenesisPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of blood pressurePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of glycolytic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nitric oxide metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid oxidationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of lipid biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of cell growth involved in cardiac muscle cell developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
enamel mineralizationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cellular response to fructose stimulusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of leukocyte cell-cell adhesionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of fatty acid transportPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone acetyltransferase p300Homo sapiens (human)
response to hypoxiaHistone acetyltransferase p300Homo sapiens (human)
somitogenesisHistone acetyltransferase p300Homo sapiens (human)
thigmotaxisHistone acetyltransferase p300Homo sapiens (human)
behavioral defense responseHistone acetyltransferase p300Homo sapiens (human)
stimulatory C-type lectin receptor signaling pathwayHistone acetyltransferase p300Homo sapiens (human)
regulation of glycolytic processHistone acetyltransferase p300Homo sapiens (human)
protein acetylationHistone acetyltransferase p300Homo sapiens (human)
internal protein amino acid acetylationHistone acetyltransferase p300Homo sapiens (human)
apoptotic processHistone acetyltransferase p300Homo sapiens (human)
canonical NF-kappaB signal transductionHistone acetyltransferase p300Homo sapiens (human)
nervous system developmentHistone acetyltransferase p300Homo sapiens (human)
heart developmentHistone acetyltransferase p300Homo sapiens (human)
skeletal muscle tissue developmentHistone acetyltransferase p300Homo sapiens (human)
learning or memoryHistone acetyltransferase p300Homo sapiens (human)
circadian rhythmHistone acetyltransferase p300Homo sapiens (human)
animal organ morphogenesisHistone acetyltransferase p300Homo sapiens (human)
regulation of autophagyHistone acetyltransferase p300Homo sapiens (human)
negative regulation of autophagyHistone acetyltransferase p300Homo sapiens (human)
macrophage derived foam cell differentiationHistone acetyltransferase p300Homo sapiens (human)
regulation of mitochondrion organizationHistone acetyltransferase p300Homo sapiens (human)
positive regulation of neuron projection developmentHistone acetyltransferase p300Homo sapiens (human)
N-terminal peptidyl-lysine acetylationHistone acetyltransferase p300Homo sapiens (human)
internal peptidyl-lysine acetylationHistone acetyltransferase p300Homo sapiens (human)
peptidyl-lysine acetylationHistone acetyltransferase p300Homo sapiens (human)
B cell differentiationHistone acetyltransferase p300Homo sapiens (human)
platelet formationHistone acetyltransferase p300Homo sapiens (human)
lung developmentHistone acetyltransferase p300Homo sapiens (human)
positive regulation of transforming growth factor beta receptor signaling pathwayHistone acetyltransferase p300Homo sapiens (human)
negative regulation of protein-containing complex assemblyHistone acetyltransferase p300Homo sapiens (human)
protein destabilizationHistone acetyltransferase p300Homo sapiens (human)
cellular response to nutrient levelsHistone acetyltransferase p300Homo sapiens (human)
cellular response to UVHistone acetyltransferase p300Homo sapiens (human)
multicellular organism growthHistone acetyltransferase p300Homo sapiens (human)
megakaryocyte developmentHistone acetyltransferase p300Homo sapiens (human)
swimmingHistone acetyltransferase p300Homo sapiens (human)
positive regulation of protein import into nucleusHistone acetyltransferase p300Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorHistone acetyltransferase p300Homo sapiens (human)
response to estrogenHistone acetyltransferase p300Homo sapiens (human)
positive regulation by host of viral transcriptionHistone acetyltransferase p300Homo sapiens (human)
fat cell differentiationHistone acetyltransferase p300Homo sapiens (human)
negative regulation of gluconeogenesisHistone acetyltransferase p300Homo sapiens (human)
transcription initiation-coupled chromatin remodelingHistone acetyltransferase p300Homo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase p300Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone acetyltransferase p300Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATHistone acetyltransferase p300Homo sapiens (human)
protein stabilizationHistone acetyltransferase p300Homo sapiens (human)
positive regulation of DNA-binding transcription factor activityHistone acetyltransferase p300Homo sapiens (human)
face morphogenesisHistone acetyltransferase p300Homo sapiens (human)
regulation of androgen receptor signaling pathwayHistone acetyltransferase p300Homo sapiens (human)
peptidyl-lysine propionylationHistone acetyltransferase p300Homo sapiens (human)
cellular response to L-leucineHistone acetyltransferase p300Homo sapiens (human)
regulation of tubulin deacetylationHistone acetyltransferase p300Homo sapiens (human)
peptidyl-lysine crotonylationHistone acetyltransferase p300Homo sapiens (human)
peptidyl-lysine butyrylationHistone acetyltransferase p300Homo sapiens (human)
regulation of cellular response to heatHistone acetyltransferase p300Homo sapiens (human)
regulation of signal transduction by p53 class mediatorHistone acetyltransferase p300Homo sapiens (human)
positive regulation of TORC1 signalingHistone acetyltransferase p300Homo sapiens (human)
positive regulation of T-helper 17 cell lineage commitmentHistone acetyltransferase p300Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of transcription from RNA polymerase II promoter by glucoseHistone acetyltransferase KAT2BHomo sapiens (human)
gluconeogenesisHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of DNA repairHistone acetyltransferase KAT2BHomo sapiens (human)
chromatin remodelingHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of DNA-templated transcriptionHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
protein acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
heart developmentHistone acetyltransferase KAT2BHomo sapiens (human)
memoryHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of cell population proliferationHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of protein ADP-ribosylationHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of neuron projection developmentHistone acetyltransferase KAT2BHomo sapiens (human)
N-terminal peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
internal peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to insulin stimulusHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to oxidative stressHistone acetyltransferase KAT2BHomo sapiens (human)
vasodilationHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of RNA splicingHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of gluconeogenesisHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of fatty acid biosynthetic processHistone acetyltransferase KAT2BHomo sapiens (human)
transcription initiation-coupled chromatin remodelingHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of glycolytic processHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of embryonic developmentHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of centriole replicationHistone acetyltransferase KAT2BHomo sapiens (human)
rhythmic processHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of cell divisionHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of cell cycleHistone acetyltransferase KAT2BHomo sapiens (human)
limb developmentHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to parathyroid hormone stimulusHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of tubulin deacetylationHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of attachment of mitotic spindle microtubules to kinetochoreHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of rRNA processingHistone acetyltransferase KAT2BHomo sapiens (human)
lipid droplet disassemblyHistone acetyltransferase KAT5Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT5Homo sapiens (human)
establishment of mitotic spindle orientationHistone acetyltransferase KAT5Homo sapiens (human)
double-strand break repair via homologous recombinationHistone acetyltransferase KAT5Homo sapiens (human)
nucleotide-excision repairHistone acetyltransferase KAT5Homo sapiens (human)
double-strand break repairHistone acetyltransferase KAT5Homo sapiens (human)
apoptotic processHistone acetyltransferase KAT5Homo sapiens (human)
DNA damage responseHistone acetyltransferase KAT5Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorHistone acetyltransferase KAT5Homo sapiens (human)
spermatid developmentHistone acetyltransferase KAT5Homo sapiens (human)
response to ionizing radiationHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of autophagyHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of triglyceride biosynthetic processHistone acetyltransferase KAT5Homo sapiens (human)
peptidyl-lysine acetylationHistone acetyltransferase KAT5Homo sapiens (human)
neural tube developmentHistone acetyltransferase KAT5Homo sapiens (human)
neurogenesisHistone acetyltransferase KAT5Homo sapiens (human)
negative regulation of interleukin-2 productionHistone acetyltransferase KAT5Homo sapiens (human)
sperm DNA condensationHistone acetyltransferase KAT5Homo sapiens (human)
cellular response to glucose starvationHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of circadian rhythmHistone acetyltransferase KAT5Homo sapiens (human)
regulation of apoptotic processHistone acetyltransferase KAT5Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processHistone acetyltransferase KAT5Homo sapiens (human)
innate immune responseHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of regulatory T cell differentiationHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of myoblast differentiationHistone acetyltransferase KAT5Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT5Homo sapiens (human)
regulation of cell cycleHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of mitotic sister chromatid segregationHistone acetyltransferase KAT5Homo sapiens (human)
cellular response to glucose stimulusHistone acetyltransferase KAT5Homo sapiens (human)
cellular response to estradiol stimulusHistone acetyltransferase KAT5Homo sapiens (human)
cellular senescenceHistone acetyltransferase KAT5Homo sapiens (human)
DNA repair-dependent chromatin remodelingHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of protein acetylationHistone acetyltransferase KAT5Homo sapiens (human)
regulation of hematopoietic stem cell differentiationHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of attachment of mitotic spindle microtubules to kinetochoreHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of double-strand break repair via homologous recombinationHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of aggrephagyHistone acetyltransferase KAT5Homo sapiens (human)
negative regulation of double-strand break repair via homologous recombinationHistone acetyltransferase KAT5Homo sapiens (human)
regulation of double-strand break repairHistone acetyltransferase KAT5Homo sapiens (human)
regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT5Homo sapiens (human)
regulation of autophagyHistone acetyltransferase KAT8Homo sapiens (human)
negative regulation of epithelial to mesenchymal transitionHistone acetyltransferase KAT8Homo sapiens (human)
neurogenesisHistone acetyltransferase KAT8Homo sapiens (human)
myeloid cell differentiationHistone acetyltransferase KAT8Homo sapiens (human)
negative regulation of type I interferon productionHistone acetyltransferase KAT8Homo sapiens (human)
post-embryonic hemopoiesisHistone acetyltransferase KAT8Homo sapiens (human)
transcription initiation-coupled chromatin remodelingHistone acetyltransferase KAT8Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone acetyltransferase KAT8Homo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase KAT8Homo sapiens (human)
oogenesisHistone acetyltransferase KAT8Homo sapiens (human)
regulation of mRNA processingHistone acetyltransferase KAT8Homo sapiens (human)
positive regulation of transcription initiation by RNA polymerase IIHistone acetyltransferase KAT8Homo sapiens (human)
positive regulation of skeletal muscle satellite cell differentiationHistone acetyltransferase KAT8Homo sapiens (human)
regulation of mitochondrial transcriptionHistone acetyltransferase KAT8Homo sapiens (human)
regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT8Homo sapiens (human)
protein ubiquitinationSUMO-activating enzyme subunit 1Homo sapiens (human)
protein sumoylationSUMO-activating enzyme subunit 1Homo sapiens (human)
positive regulation of protein sumoylationSUMO-activating enzyme subunit 1Homo sapiens (human)
positive regulation of protein targeting to mitochondrionSUMO-activating enzyme subunit 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (103)

Processvia Protein(s)Taxonomy
serine-type endopeptidase activityPlasma kallikreinHomo sapiens (human)
protein bindingPlasma kallikreinHomo sapiens (human)
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
transcription cis-regulatory region bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
transcription coregulator bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleic acid bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
chromatin bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
double-stranded DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
prostaglandin receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
enzyme bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
peptide bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
identical protein bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
sequence-specific DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nuclear retinoid X receptor bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
arachidonic acid bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA binding domain bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
LBD domain bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
alpha-actinin bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
R-SMAD bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
E-box bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
STAT family protein bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
transcription coactivator bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nuclear steroid receptor activityPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
lipid bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
linoleic acid bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
sequence-specific double-stranded DNA bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription activator activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
transcription coactivator bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nuclear steroid receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
lipid bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
phosphatase bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein domain specific bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
mitogen-activated protein kinase kinase kinase bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
ubiquitin conjugating enzyme bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
sequence-specific DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein-containing complex bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
NFAT protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
MDM2/MDM4 family protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
transcription coregulator bindingHistone acetyltransferase p300Homo sapiens (human)
transcription coactivator bindingHistone acetyltransferase p300Homo sapiens (human)
p53 bindingHistone acetyltransferase p300Homo sapiens (human)
DNA bindingHistone acetyltransferase p300Homo sapiens (human)
chromatin bindingHistone acetyltransferase p300Homo sapiens (human)
damaged DNA bindingHistone acetyltransferase p300Homo sapiens (human)
transcription coactivator activityHistone acetyltransferase p300Homo sapiens (human)
histone acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
lysine N-acetyltransferase activity, acting on acetyl phosphate as donorHistone acetyltransferase p300Homo sapiens (human)
protein bindingHistone acetyltransferase p300Homo sapiens (human)
beta-catenin bindingHistone acetyltransferase p300Homo sapiens (human)
zinc ion bindingHistone acetyltransferase p300Homo sapiens (human)
histone H3 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone H4 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
acyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
nuclear receptor bindingHistone acetyltransferase p300Homo sapiens (human)
peptide N-acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone H3K18 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone H2B acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone H3K27 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
tau protein bindingHistone acetyltransferase p300Homo sapiens (human)
nuclear androgen receptor bindingHistone acetyltransferase p300Homo sapiens (human)
NF-kappaB bindingHistone acetyltransferase p300Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingHistone acetyltransferase p300Homo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
protein propionyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
pre-mRNA intronic bindingHistone acetyltransferase p300Homo sapiens (human)
STAT family protein bindingHistone acetyltransferase p300Homo sapiens (human)
peptide 2-hydroxyisobutyryltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone lactyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
acetylation-dependent protein bindingHistone acetyltransferase p300Homo sapiens (human)
peptide butyryltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone crotonyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone butyryltransferase activityHistone acetyltransferase p300Homo sapiens (human)
DNA-binding transcription factor bindingHistone acetyltransferase p300Homo sapiens (human)
histone H3K122 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
chromatin DNA bindingHistone acetyltransferase p300Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingHistone acetyltransferase KAT2BHomo sapiens (human)
chromatin bindingHistone acetyltransferase KAT2BHomo sapiens (human)
transcription coregulator activityHistone acetyltransferase KAT2BHomo sapiens (human)
transcription coactivator activityHistone acetyltransferase KAT2BHomo sapiens (human)
diamine N-acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
histone acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
lysine N-acetyltransferase activity, acting on acetyl phosphate as donorHistone acetyltransferase KAT2BHomo sapiens (human)
cyclin-dependent protein serine/threonine kinase inhibitor activityHistone acetyltransferase KAT2BHomo sapiens (human)
protein bindingHistone acetyltransferase KAT2BHomo sapiens (human)
acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
protein kinase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone acetyltransferase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone deacetylase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone H3K9 acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
DNA-binding transcription factor bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone H3 acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
chromatin bindingHistone acetyltransferase KAT5Homo sapiens (human)
transcription coactivator activityHistone acetyltransferase KAT5Homo sapiens (human)
histone acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
protein bindingHistone acetyltransferase KAT5Homo sapiens (human)
histone H4 acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
histone H2A acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
histone H2AK5 acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
metal ion bindingHistone acetyltransferase KAT5Homo sapiens (human)
histone H4K16 acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
peptide 2-hydroxyisobutyryltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
peptide crotonyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
peptide butyryltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
DNA-binding transcription factor bindingHistone acetyltransferase KAT5Homo sapiens (human)
transcription coregulator activityHistone acetyltransferase KAT5Homo sapiens (human)
histone H4K5 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K8 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K16 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
transcription coactivator activityHistone acetyltransferase KAT8Homo sapiens (human)
protein bindingHistone acetyltransferase KAT8Homo sapiens (human)
histone H4 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
enzyme bindingHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K5 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K8 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
metal ion bindingHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K16 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingHistone acetyltransferase KAT8Homo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
protein propionyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
transcription coregulator activityHistone acetyltransferase KAT8Homo sapiens (human)
chromatin bindingHistone acetyltransferase KAT8Homo sapiens (human)
SUMO activating enzyme activitySUMO-activating enzyme subunit 1Homo sapiens (human)
ubiquitin activating enzyme activitySUMO-activating enzyme subunit 1Homo sapiens (human)
protein bindingSUMO-activating enzyme subunit 1Homo sapiens (human)
enzyme activator activitySUMO-activating enzyme subunit 1Homo sapiens (human)
ATP-dependent protein bindingSUMO-activating enzyme subunit 1Homo sapiens (human)
small protein activating enzyme bindingSUMO-activating enzyme subunit 1Homo sapiens (human)
protein heterodimerization activitySUMO-activating enzyme subunit 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (40)

Processvia Protein(s)Taxonomy
extracellular regionPlasma kallikreinHomo sapiens (human)
extracellular spacePlasma kallikreinHomo sapiens (human)
plasma membranePlasma kallikreinHomo sapiens (human)
extracellular exosomePlasma kallikreinHomo sapiens (human)
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
nucleusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cytosolPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
intracellular membrane-bounded organellePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
RNA polymerase II transcription regulator complexPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
receptor complexPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cytoplasmHistone acetyltransferase p300Homo sapiens (human)
cytosolHistone acetyltransferase p300Homo sapiens (human)
nucleusHistone acetyltransferase p300Homo sapiens (human)
nucleoplasmHistone acetyltransferase p300Homo sapiens (human)
cytosolHistone acetyltransferase p300Homo sapiens (human)
chromatinHistone acetyltransferase p300Homo sapiens (human)
protein-DNA complexHistone acetyltransferase p300Homo sapiens (human)
transcription regulator complexHistone acetyltransferase p300Homo sapiens (human)
histone acetyltransferase complexHistone acetyltransferase p300Homo sapiens (human)
SAGA complexHistone acetyltransferase KAT2BHomo sapiens (human)
kinetochoreHistone acetyltransferase KAT2BHomo sapiens (human)
nucleusHistone acetyltransferase KAT2BHomo sapiens (human)
nucleoplasmHistone acetyltransferase KAT2BHomo sapiens (human)
centrosomeHistone acetyltransferase KAT2BHomo sapiens (human)
cytosolHistone acetyltransferase KAT2BHomo sapiens (human)
A bandHistone acetyltransferase KAT2BHomo sapiens (human)
I bandHistone acetyltransferase KAT2BHomo sapiens (human)
actomyosinHistone acetyltransferase KAT2BHomo sapiens (human)
mitotic spindleHistone acetyltransferase KAT2BHomo sapiens (human)
ATAC complexHistone acetyltransferase KAT2BHomo sapiens (human)
protein-containing complexHistone acetyltransferase KAT2BHomo sapiens (human)
site of double-strand breakHistone acetyltransferase KAT5Homo sapiens (human)
kinetochoreHistone acetyltransferase KAT5Homo sapiens (human)
nucleosomeHistone acetyltransferase KAT5Homo sapiens (human)
nucleusHistone acetyltransferase KAT5Homo sapiens (human)
nucleoplasmHistone acetyltransferase KAT5Homo sapiens (human)
nucleolusHistone acetyltransferase KAT5Homo sapiens (human)
cytoplasmHistone acetyltransferase KAT5Homo sapiens (human)
cytosolHistone acetyltransferase KAT5Homo sapiens (human)
piccolo histone acetyltransferase complexHistone acetyltransferase KAT5Homo sapiens (human)
NuA4 histone acetyltransferase complexHistone acetyltransferase KAT5Homo sapiens (human)
intracellular membrane-bounded organelleHistone acetyltransferase KAT5Homo sapiens (human)
perinuclear region of cytoplasmHistone acetyltransferase KAT5Homo sapiens (human)
mitotic spindle poleHistone acetyltransferase KAT5Homo sapiens (human)
chromatinHistone acetyltransferase KAT5Homo sapiens (human)
Swr1 complexHistone acetyltransferase KAT5Homo sapiens (human)
transcription regulator complexHistone acetyltransferase KAT5Homo sapiens (human)
nucleusHistone acetyltransferase KAT5Homo sapiens (human)
nucleusHistone acetyltransferase KAT8Homo sapiens (human)
chromosomeHistone acetyltransferase KAT8Homo sapiens (human)
kinetochoreHistone acetyltransferase KAT8Homo sapiens (human)
nucleusHistone acetyltransferase KAT8Homo sapiens (human)
nucleoplasmHistone acetyltransferase KAT8Homo sapiens (human)
mitochondrionHistone acetyltransferase KAT8Homo sapiens (human)
nuclear matrixHistone acetyltransferase KAT8Homo sapiens (human)
NSL complexHistone acetyltransferase KAT8Homo sapiens (human)
MSL complexHistone acetyltransferase KAT8Homo sapiens (human)
histone acetyltransferase complexHistone acetyltransferase KAT8Homo sapiens (human)
MLL1 complexHistone acetyltransferase KAT8Homo sapiens (human)
chromatinHistone acetyltransferase KAT8Homo sapiens (human)
NuA4 histone acetyltransferase complexHistone acetyltransferase KAT8Homo sapiens (human)
nucleusSUMO-activating enzyme subunit 1Homo sapiens (human)
nucleoplasmSUMO-activating enzyme subunit 1Homo sapiens (human)
SUMO activating enzyme complexSUMO-activating enzyme subunit 1Homo sapiens (human)
cytoplasmSUMO-activating enzyme subunit 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (74)

Assay IDTitleYearJournalArticle
AID1803987SARS-CoV-2 CPE assay from Article 10.1101/2020.07.17.207019: \\Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening.\\2020bioRxiv : the preprint server for biology, Aug-11Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening.
AID18039863CLpro enzyme assay from Article 10.1101/2020.07.17.207019: \\Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening.\\2020bioRxiv : the preprint server for biology, Aug-11Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening.
AID1377703Inhibition of p300 (unknown origin)2017European journal of medicinal chemistry, Sep-29, Volume: 138Antiproliferative and apoptotic activities of sequence-specific histone acetyltransferase inhibitors.
AID1901636Agonist activity at human PPARgamma in mouse 3T3-L1 cells assessed as induction of adipogenic differentiation at 10 uM measured after 11 days by Oil Red O staining analysis2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1082429Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 5 mg/mL2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Effects of Ginkgo biloba constituents on fruit-infesting behavior of codling moth (Cydia pomonella) in apples.
AID1831867Antineuroinflammatory activity in mouse BV-2 cells assessed as suppression of LPS-induced IL-1beta mRNA expression at 0.1 uM preincubated for 24 hrs followed by LPS stimulation and measured after 24 hrs by RT-PCR analysis2021Journal of medicinal chemistry, 04-22, Volume: 64, Issue:8
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease.
AID1633668Permeability of the compound at pH 7.4 PBS buffer at 100 uM measured upto 6 hrs by PAMPA-BBB assay2019ACS medicinal chemistry letters, Apr-11, Volume: 10, Issue:4
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease.
AID1901642Agonist activity at human PPARdelta expressed in HEK293 cells by luciferase/beta-galactosidase reporter gene assay2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1262167Inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as reduction of Co A level using histone H4 substrate at 400 uM after 15 mins by CPM fluorescence assay2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID1831863Cytotoxicity against human HepG2 cells assessed as cell viability at 10 uM after 24 hrs by MTT assay2021Journal of medicinal chemistry, 04-22, Volume: 64, Issue:8
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease.
AID1262173Inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as Vmax for histone H4 peptide at 80 uM (Rvb = 13 +/- 0.7 pmol/min)2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID713972Inhibition of potato 5-lipoxygenase assessed as residual activity at 6 uM preincubated for 10 mins measured by real-time spectrophotometric analysis2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
AID1859350Inhibition of His-tagged SUMO1/GST-tagged Aos1/Uba2/His-tagged Ubc9 (unknown origin)-mediated recombinant His/T7-tagged RanGAP1-C-terminal fragment SUMOylation expressed in Escherichia coli BL21 (DE3) assessed as reduction in Ubc9-SUMO level in presence o2022European journal of medicinal chemistry, Apr-05, Volume: 233Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
AID1282369Inhibition of full length recombinant human His6-tagged p300 expressed in baculovirus infected Sf21 cells using N-terminal H3 peptide substrate after 10 mins by radiometric filter binding assay in presence of [3H]acetyl-CoA2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
AID348950Antibacterial activity against Streptococcus mutans ATCC 25175 after 2 days by twofold broth dilution method2008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Design and evaluation of anacardic acid derivatives as anticavity agents.
AID1901634Agonist activity at human PPARgamma transfected in HEK293 cells assessed as relative luciferase unit at 50 uM measured after 16 hrs by luciferase reporter gene assay2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1901643Agonist activity at human PPARalpha expressed in HEK293 cells assessed as maximal activity by luciferase/beta-galactosidase reporter gene assay relative to GW76472022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1891409Inhibition of SARS-CoV-2 main protease expressed in Escherichia coli using DABCYL-KTSAVLQ1SGFRKM-E(EDANS)-NH2 peptide as substrate at 100 uM incubated for 30 mins by FRET based assay relative to control
AID1262174Inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as Vmax for histone H4 peptide at 160 uM (Rvb = 13 +/- 0.7 pmol/min)2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID1262180Inhibition of human recombinant Histone acetyltransferase p300 catalytic domain (1284-1672 residues) using [3H]Acetyl-CoA and histone H3 substrate at 50 uM after 1 hr by liquid scintillation counting2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID1901633Agonist activity at human PPARalpha transfected in HEK293 cells assessed as relative luciferase unit at 50 uM measured after 16 hrs by luciferase reporter gene assay2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1282371Inhibition of recombinant human PCAF catalytic domain (492 to 658 residues) using histone H3 peptide substrate after 1 hr by liquid scintillation counting method in presence of [3H]acetyl-CoA2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
AID1282401Inhibition of recombinant p300 catalytic domain (unknown origin) using N-terminal histone H3 substrate at 52 uM by orthogonal fluorescence assay in presence of [3H]acetyl-CoA relative to control2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
AID1262179Inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as reduction of Co A level using histone H4 substrate after 15 mins by CPM fluorescence assay2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID1422600Inhibition of MOF (unknown origin)2018Bioorganic & medicinal chemistry, 11-01, Volume: 26, Issue:20
Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.
AID713977Inhibition of soybean lipoxygenase-1 assessed as formation of 13-HPOD from linolenic acid preincubated for 10 mins measured by real-time spectrophotometric analysis2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
AID713982Critical micelles concentration of the compound in 0.2 M borate buffer at pH 92012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
AID1891410Inhibition of SARS-CoV-2 main protease expressed in Escherichia coli using DABCYL-KTSAVLQ1SGFRKM-E(EDANS)-NH2 peptide as substrate incubated for 30 mins by FRET based assay
AID1282361Inhibition of recombinant p300 catalytic domain (unknown origin) using N-terminal histone H3 substrate by radiometric filter binding assay in presence of [3H]acetyl-CoA2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
AID713973Inhibition of potato 5-lipoxygenase assessed as residual activity preincubated for 10 mins measured by real-time spectrophotometric analysis2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
AID1082427Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 0.5 mg/mL2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Effects of Ginkgo biloba constituents on fruit-infesting behavior of codling moth (Cydia pomonella) in apples.
AID1203126Inhibition of PCAF (unknown origin) using histone H3/[acetyl-3H]-acetyl coenzyme A as substrate2015Journal of medicinal chemistry, Mar-26, Volume: 58, Issue:6
A novel cell-permeable, selective, and noncompetitive inhibitor of KAT3 histone acetyltransferases from a combined molecular pruning/classical isosterism approach.
AID1203125Inhibition of PCAF (unknown origin) using histone H3/[acetyl-3H]-acetyl coenzyme A as substrate at 10 uM2015Journal of medicinal chemistry, Mar-26, Volume: 58, Issue:6
A novel cell-permeable, selective, and noncompetitive inhibitor of KAT3 histone acetyltransferases from a combined molecular pruning/classical isosterism approach.
AID1082436Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 1 mg/mL2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Effects of Ginkgo biloba constituents on fruit-infesting behavior of codling moth (Cydia pomonella) in apples.
AID1901645Agonist activity at human PPARdelta expressed in HEK293 cells assessed as maximal activity by luciferase/beta-galactosidase reporter gene assay relative to GW07422022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1262171Uncompetitive inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as Km for acetyl coenzyme A at 160 uM (Rvb = 4.8 +/- 0.5 uM)2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID1901640Agonist activity at human PPARalpha expressed in HEK293 cells by luciferase/beta-galactosidase reporter gene assay2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1262178Inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as half-maximal velocity for histone H4 peptide at 240 uM (Rvb = 36 uM)2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID1901641Agonist activity at human PPARgamma expressed in HEK293 cells by luciferase/beta-galactosidase reporter gene assay2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1901648Agonist activity at human PPARalpha in mouse hepatocytes assessed as induction of Fgf21 mRNA expression at 50 uM incubated for 16 hrs by quantitative real-time PCR analysis2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1831868Antineuroinflammatory activity in mouse BV-2 cells assessed as suppression of LPS-induced COX-2 mRNA expression at 0.1 uM preincubated for 24 hrs followed by LPS stimulation and measured after 24 hrs by RT-PCR analysis2021Journal of medicinal chemistry, 04-22, Volume: 64, Issue:8
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease.
AID727132Inhibition of recombinant SAE1(unknown origin)-mediated SUMOylation of RanGAP1-C22013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Exploring a new frontier in cancer treatment: targeting the ubiquitin and ubiquitin-like activating enzymes.
AID1422598Inhibition of recombinant FLAG epitope-tagged human PCAF expressed in Baculovirus-infected Sf21 cells using histone peptide as substrate after 10 mins in presence of [14C]-acetyl CoA by liquid scintillation counting analysis2018Bioorganic & medicinal chemistry, 11-01, Volume: 26, Issue:20
Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.
AID1262175Inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as Vmax for histone H4 peptide at 240 uM (Rvb = 13 +/- 0.7 pmol/min)2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID1058856Inhibition of human 5-LOX using lionleic acid as substrate assessed as formation of 13-HPOD at 50 uM incubated for 10 mins prior to substrate addition measured after 10 secs by UV absorbance assay2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery of a novel activator of 5-lipoxygenase from an anacardic acid derived compound collection.
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
AID348953Antibacterial activity against Escherichia coli ATCC 9637 up to 200 ug/ml after 2 days by twofold broth dilution method2008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Design and evaluation of anacardic acid derivatives as anticavity agents.
AID1528818Inhibition of recombinant human full-length His6-tagged p300 expressed in baculovirus infected Sf21 insect cells using [3H]acetylCoA as substrate preincubated for 10 mins followed by substrate addition and measured after 10 mins by liquid scintillation co
AID1082426Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 0.2 mg/mL2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Effects of Ginkgo biloba constituents on fruit-infesting behavior of codling moth (Cydia pomonella) in apples.
AID1831871Antineuroinflammatory activity in mouse BV-2 cells assessed as reduction in LPS-induced NF-kappaB nuclear translocation at 0.1 uM preincubated for 24 hrs followed by LPS stimulation and measured after 24 hrs by confocal immunofluorescence assay2021Journal of medicinal chemistry, 04-22, Volume: 64, Issue:8
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease.
AID1058855Inhibition of human COX2 using arachidonic acid as substrate assessed as formation of TMPD at 50 uM incubated for 5 mins prior to substrate addition measured after 5 mins by spectrophotometry2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery of a novel activator of 5-lipoxygenase from an anacardic acid derived compound collection.
AID1831861Cytotoxicity against human HepG2 cells assessed as cell viability at 0.1 uM after 24 hrs by MTT assay2021Journal of medicinal chemistry, 04-22, Volume: 64, Issue:8
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease.
AID1262168Uncompetitive inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as Vmax for acetyl coenzyme A at 160 uM (Rvb = 17 +/- 0.7 pmol/min)2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID713976Inhibition of potato 5-lipoxygenase assessed as residual activity at 50 uM preincubated for 10 mins measured by real-time spectrophotometric analysis2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
AID1262172Uncompetitive inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as Km for acetyl coenzyme A at 240 uM (Rvb = 4.8 +/- 0.5 uM)2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID348952Antibacterial activity against Propionibacterium acnes ATCC 118272008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Design and evaluation of anacardic acid derivatives as anticavity agents.
AID1262176Inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as half-maximal velocity for histone H4 peptide at 80 uM (Rvb = 36 uM)2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID1082428Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 2 mg/mL2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Effects of Ginkgo biloba constituents on fruit-infesting behavior of codling moth (Cydia pomonella) in apples.
AID1422597Inhibition of recombinant His6-tagged human P300 expressed in Baculovirus-infected Sf21 cells using histone peptide as substrate after 10 mins in presence of [14C]-acetyl CoA by liquid scintillation counting analysis2018Bioorganic & medicinal chemistry, 11-01, Volume: 26, Issue:20
Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.
AID1901649Agonist activity at human PPARalpha in mouse hepatocytes assessed as induction of Pdk4 mRNA expression at 50 uM incubated for 16 hrs by quantitative real-time PCR analysis2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1262170Uncompetitive inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as Km for acetyl coenzyme A at 80 uM (Rvb = 4.8 +/- 0.5 uM)2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID1262177Inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as half-maximal velocity for histone H4 peptide at 160 uM (Rvb = 36 uM)2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID1203124Inhibition of PCAF (unknown origin) using histone H3/[acetyl-3H]-acetyl coenzyme A as substrate at 100 uM2015Journal of medicinal chemistry, Mar-26, Volume: 58, Issue:6
A novel cell-permeable, selective, and noncompetitive inhibitor of KAT3 histone acetyltransferases from a combined molecular pruning/classical isosterism approach.
AID1377701Inhibition of p300 (unknown origin) using H3 peptide and acetyl-coA as substrate by fluorometric assay2017European journal of medicinal chemistry, Sep-29, Volume: 138Antiproliferative and apoptotic activities of sequence-specific histone acetyltransferase inhibitors.
AID1901644Agonist activity at human PPARgamma expressed in HEK293 cells assessed as maximal activity by luciferase/beta-galactosidase reporter gene assay relative to rosiglitazone2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1422599Inhibition of Tip60 (unknown origin)2018Bioorganic & medicinal chemistry, 11-01, Volume: 26, Issue:20
Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.
AID1262169Uncompetitive inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as Vmax for acetyl coenzyme A at 240 uM (Rvb = 17 +/- 0.7 pmol/min)2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID1831862Cytotoxicity against human HepG2 cells assessed as cell viability at 1 uM after 24 hrs by MTT assay2021Journal of medicinal chemistry, 04-22, Volume: 64, Issue:8
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease.
AID1725879Inhibition of SUMO1 (unknown origin) assessed as reduction in SUMOylated RanGAP1 level at 50 uM incubated for 60 mins by western blot analysis2020ACS medicinal chemistry letters, Nov-12, Volume: 11, Issue:11
Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation Inhibitors.
AID713975Inhibition of soybean lipoxygenase-1 assessed as residual activity at 50 uM preincubated for 10 mins measured after 20 mins by real-time spectrophotometric analysis2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
AID1282370Inhibition of full length recombinant human FLAG-tagged PCAF expressed in baculovirus infected Sf21 cells using N-terminal H3 peptide substrate after 10 mins by radiometric filter binding assay in presence of [3H]acetyl-CoA2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
AID1262166Uncompetitive inhibition of recombinant N-terminal His6-tagged KAT8 (unknown origin) expressed in Escherichia Coli BL21 DE3 cells assessed as Vmax for acetyl coenzyme A at 80 uM (Rvb = 17 +/- 0.7 pmol/min)2015European journal of medicinal chemistry, Nov-13, Volume: 105Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
AID1745854NCATS anti-infectives library activity on HEK293 viability as a counter-qHTS vs the C. elegans viability qHTS2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1745855NCATS anti-infectives library activity on the primary C. elegans qHTS viability assay2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (174)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's10 (5.75)18.2507
2000's34 (19.54)29.6817
2010's96 (55.17)24.3611
2020's34 (19.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.00 (24.57)
Research Supply Index5.19 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index87.87 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (55.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.56%)5.53%
Reviews5 (2.82%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (0.56%)0.25%
Other170 (96.05%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]